The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research
Pharmacoeconomic Fellowship Survey

Vittorio Maio, PharmD and Jennifer H. Lofland, PharmD, MPH; Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia, USA

The Pharmacoeconomic Fellowship Program Survey conducted December 2001 was an initiative of the ISPOR Fellowship Task Force. Even though more than a decade of pharmacoeconomic fellowship programs have been in existence, the effectiveness of these programs has not been determined.1 The objectives of this survey are: a) to determine the current structure, process, and outcomes of existing fellowship programs, b) to determine to what extent do these fellowship programs accomplish their role of augmenting pharmacoeconomic skills and abilities of the recipients, and c) to determine whether pharmacoeconomic fellowship programs are following published guidelines such as the American College of Clinical Pharmacy (ACCP) guidelines.2

The Taskforce developed a set of three questionnaires, one for fellows currently enrolled in a fellowship program, one for former fellows who completed a fellowship program, and one for fellowship preceptors. The survey was conducted via the ISPOR website. Fellows and preceptors involved in a pharmacoeconomic fellowship program were identified collecting information from different sources including the ACCP and ISPOR directories of pharmacoeconomic fellowships.3,4 In addition, participants were recruited through the ISPOR website, as well as through the ISPOR membership. Survey responses were collected at the ISPOR website. All collected data are kept confidential in the study file. A total of 34 current fellows, 68 former fellows, and 49 preceptors completed the web-based survey. Survey results will be presented as a poster entitled “Evaluating the Structure of Pharmacoeconomic Fellowship Programs” at the upcoming 7th Annual International Meeting in Arlington, VA on May 21 (Poster Session II, 8:00AM-7:00PM). In addition, survey outcomes will be discussed at the workshop entitled “Paving a Road to Success: How to Obtain an Outcomes Research Fellowship within the Pharmaceutical Industry” on May 21 (Workshop Session III, 2:45-3:45PM).

We would like to express our gratitude to the numerous pharmacoeconomic fellows and preceptors who completed the questionnaires. If you would like to receive additional information concerning the survey, please contact Vittorio Maio at

Acknowledgements: We would like to thank the following people for their assistance and support: Marilyn Dix Smith and the ISPOR staff, Nelda Johnson, and the ISPOR Fellowship Task Force members (Zeba Khan, Sandeep Duttagupta, Sujit S. Sansgiry, QuynhChau Doan, Krista Yokoyama, Jennifer Sung, Amishi Shah, Amy Phillips).

  1. Maio V, Girts TK, Lofland JH, Nash DB. Pharmacoeconomic fellowships: the need for outcome measures. Pharmacoeconomics. 2001;19: 795-802
  2. Lee J, Lawrence BJ, Sullivan SD, et al. Guidelines for pharmacoeconomic research fellowship. Pharmacotherapy 1999;19:1105-9
  3. American College of Clinical Pharmacy. Directory of Residencies and Fellowships. Available from: URL: [Accessed 2001 Sept 19]
  4. International Society for Pharmacoeconomics and Outcomes Research. ISPOR directory of fellowships in pharmacoeconomics, health economics, outcomes research or related field study. Available from: URL: [Accessed 2001 Sept 19]

  Issues Index | 2002 Issues Index